Global Sulphonamides Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Sulphonamides Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Sulfonamides (sulphonamides) are a group of man-made (synthetic) medicines that contain the sulfonamide chemical group. They may also be called sulfa drugs. Many people use the term sulfonamide imprecisely to refer only to antibiotics that have a sulfonamide functional group in their chemical structure.
Sulphonamides report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Sulphonamides market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Skin Infections and Gastro Intestinal Tract (GIT) Infection are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Sulphonamides industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Sulphonamides key manufacturers include Abbott Laboratories, Boehringer Ingelheim Pharmaceuticals, Bayer AG, GlaxoSmithKline, King Pharmaceuticals, Mylan Pharmaceuticals, Novartis International AG, Pfizer and Par Pharmaceutical, etc. Abbott Laboratories, Boehringer Ingelheim Pharmaceuticals, Bayer AG are top 3 players and held % sales share in total in 2022.
Sulphonamides can be divided into Orally Absorbable Sulfonamide, Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine) and Topical Agents (Silver sulfadiazine, sulfacetamide, mafenide),, etc. Orally Absorbable Sulfonamide is the mainstream product in the market, accounting for % sales share globally in 2022.
Sulphonamides is widely used in various fields, such as Skin Infections, Gastro Intestinal Tract (GIT) Infection and Meningitis,, etc. Skin Infections provides greatest supports to the Sulphonamides industry development. In 2022, global % sales of Sulphonamides went into Skin Infections filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Sulphonamides market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Abbott Laboratories
Boehringer Ingelheim Pharmaceuticals
Bayer AG
GlaxoSmithKline
King Pharmaceuticals
Mylan Pharmaceuticals
Novartis International AG
Pfizer
Par Pharmaceutical
Roche Holding AG
Sanofi Aventis
Stiefel Laboratories
Segment by Type
Orally Absorbable Sulfonamide
Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)
Topical Agents (Silver sulfadiazine, sulfacetamide, mafenide)
Skin Infections
Gastro Intestinal Tract (GIT) Infection
Meningitis
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Sulphonamides market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Sulphonamides, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Sulphonamides industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Sulphonamides in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Sulphonamides introduction, etc. Sulphonamides Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Sulphonamides market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Sulphonamides report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Sulphonamides market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Skin Infections and Gastro Intestinal Tract (GIT) Infection are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Sulphonamides industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Sulphonamides key manufacturers include Abbott Laboratories, Boehringer Ingelheim Pharmaceuticals, Bayer AG, GlaxoSmithKline, King Pharmaceuticals, Mylan Pharmaceuticals, Novartis International AG, Pfizer and Par Pharmaceutical, etc. Abbott Laboratories, Boehringer Ingelheim Pharmaceuticals, Bayer AG are top 3 players and held % sales share in total in 2022.
Sulphonamides can be divided into Orally Absorbable Sulfonamide, Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine) and Topical Agents (Silver sulfadiazine, sulfacetamide, mafenide),, etc. Orally Absorbable Sulfonamide is the mainstream product in the market, accounting for % sales share globally in 2022.
Sulphonamides is widely used in various fields, such as Skin Infections, Gastro Intestinal Tract (GIT) Infection and Meningitis,, etc. Skin Infections provides greatest supports to the Sulphonamides industry development. In 2022, global % sales of Sulphonamides went into Skin Infections filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Sulphonamides market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Abbott Laboratories
Boehringer Ingelheim Pharmaceuticals
Bayer AG
GlaxoSmithKline
King Pharmaceuticals
Mylan Pharmaceuticals
Novartis International AG
Pfizer
Par Pharmaceutical
Roche Holding AG
Sanofi Aventis
Stiefel Laboratories
Segment by Type
Orally Absorbable Sulfonamide
Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)
Topical Agents (Silver sulfadiazine, sulfacetamide, mafenide)
Segment by Application
Skin Infections
Gastro Intestinal Tract (GIT) Infection
Meningitis
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Sulphonamides market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Sulphonamides, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Sulphonamides industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Sulphonamides in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Sulphonamides introduction, etc. Sulphonamides Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Sulphonamides market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices